Bita Saleh
Using her 30-years of dental and certified professional coaching experience, Bita Saleh D.D.S. teaches dentists to meet profit goals consistently, increase treatment plan acceptance, decrease no-shows and last-minute cancellations, and attract high-value new patients while retaining existing patients. At the end of
The Foundation of Profitable Dentistry, dentists will see, know, and trust themselves as a leader.
The Foundation of Profitable Dentistry guides dentists in building a dental practice that is profitable and sustainable year-after-year. Bita Saleh D.D.S. helps them to naturally discover with ease, clarity, and confidence the most resonant next steps for creating and maintaining a stress-free and profitable practice.
January 12, 2021
Avishai Sadan, dean of the Herman Ostrow School of Dentistry of USC, receives the first dose of his COVID-19 vaccination from Guadalupe Felix. (USC Photo/Gus Ruelas)
As part of phase 1A of the vaccination rollout, health professional students, faculty and staff who are in direct contact with patients or collect specimens have been invited to sign up for their vaccinations at the Lyon Center. Other units included in this phase are the Keck School of Medicine of USC and the USC School of Pharmacy.
Dental faculty, students and staff were invited as the first group to be vaccinated on the University Park Campus. Dean Avishai Sadan and Associate Dean Douglas Solow were on hand to support their students as they were vaccinated. The Ostrow School also actively assisted with the proceedings, sending dozens of dental students to help prepare the vaccines in the USC Student Health immunization clinic and pitch in at the vaccine site.
Stem cells fix skull shape, brain function in mouse model of childhood disorder
Scientists regenerate parts of the skull affected by craniosynostosis, a common birth defect
Using stem cells to regenerate parts of the skull, scientists corrected skull shape and reversed learning and memory deficits in young mice with craniosynostosis, a condition estimated to affect 1 in every 2,500 infants born in the United States, according to the Centers for Disease Control and Prevention. The only current therapy is complex surgery within the first year of life, but skull defects often return afterward. The study, supported by the National Institute of Dental and Craniofacial Research (NIDCR), could pave the way for more effective and less invasive therapies for children with craniosynostosis. The findings were published Jan. 7, 2021 in
E-Mail
IMAGE: A stem cell-based treatment given to young mice with craniosynostosis regenerated the flexible joints between skull bones and restored skull shape and size (right), compared to untreated animals (left), as. view more
Credit: Amanda Frataccia, USC
Using stem cells to regenerate parts of the skull, scientists corrected skull shape and reversed learning and memory deficits in young mice with craniosynostosis, a condition estimated to affect 1 in every 2,500 infants born in the United States, according to the Centers for Disease Control and Prevention. The only current therapy is complex surgery within the first year of life, but skull defects often return afterward. The study, supported by the National Institute of Dental and Craniofacial Research (NIDCR), could pave the way for more effective and less invasive therapies for children with craniosynostosis. The findings were published Jan. 7, 2021 in